VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer
Videos  >  

The Future of Immune Checkpoint Inhibition in Gastric and Esophageal Cancers

Geoffrey Y. Ku, MD
Published Online:3:19 PM, Thu February 2, 2017

Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.